New olanzapine shots tested for steadier effect in schizophrenia
NCT ID NCT06319170
First seen Jan 11, 2026 · Last updated May 18, 2026 · Updated 15 times
Summary
This study tested three different slow-release versions of the drug olanzapine, given as a shot under the skin, in 106 adults with schizophrenia or schizoaffective disorder. The main goal was to measure how the drug enters the blood and how long it stays. Researchers also checked for side effects over 28 days. The study is complete and helps understand which version might work best for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA / SCHIZOAFFECTIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Teva Investigational Site 15726
Marlton, New Jersey, 08053, United States
-
Teva Investigational Site 15727
Hollywood, Florida, 33024, United States
-
Teva Investigational Site 15728
Decatur, Georgia, 30030, United States
-
Teva Investigational Site 15729
Atlanta, Georgia, 30331, United States
-
Teva Investigational Site 15730
Los Alamitos, California, 90720, United States
Conditions
Explore the condition pages connected to this study.